Correction: Treatment of triple-negative breast cancer with TORC1/2 inhibitors sustains a drug-resistant and Notch-dependent cancer stem cell population (Cancer Research (2016) 76 (440–452) DOI: 10.1158/0008-5472.CAN-15-1640-T)

Neil E. Bhola, Valerie M. Jansen, James P. Koch, Hua Li, Luigi Formisano, Janice A. Williams, Jennifer R. Grandis, Carlos L. Arteaga

Research output: Contribution to journalComment/debate

Abstract

In the original version of this article (1), the stated disclosure of the author Carlos L. Arteaga is incorrect. The error has been corrected in the latest online HTML and PDF versions of the article. The authors regret this error.

Original languageEnglish (US)
Number of pages1
JournalCancer Research
Volume79
Issue number4
DOIs
StatePublished - Feb 15 2019

Fingerprint

Triple Negative Breast Neoplasms
Neoplastic Stem Cells
Disclosure
Emotions
Research
Pharmaceutical Preparations
Population
Neoplasms
mechanistic target of rapamycin complex 1

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

Correction : Treatment of triple-negative breast cancer with TORC1/2 inhibitors sustains a drug-resistant and Notch-dependent cancer stem cell population (Cancer Research (2016) 76 (440–452) DOI: 10.1158/0008-5472.CAN-15-1640-T). / Bhola, Neil E.; Jansen, Valerie M.; Koch, James P.; Li, Hua; Formisano, Luigi; Williams, Janice A.; Grandis, Jennifer R.; Arteaga, Carlos L.

In: Cancer Research, Vol. 79, No. 4, 15.02.2019.

Research output: Contribution to journalComment/debate

@article{a729f96d054a4d24b3c180914f61c420,
title = "Correction: Treatment of triple-negative breast cancer with TORC1/2 inhibitors sustains a drug-resistant and Notch-dependent cancer stem cell population (Cancer Research (2016) 76 (440–452) DOI: 10.1158/0008-5472.CAN-15-1640-T)",
abstract = "In the original version of this article (1), the stated disclosure of the author Carlos L. Arteaga is incorrect. The error has been corrected in the latest online HTML and PDF versions of the article. The authors regret this error.",
author = "Bhola, {Neil E.} and Jansen, {Valerie M.} and Koch, {James P.} and Hua Li and Luigi Formisano and Williams, {Janice A.} and Grandis, {Jennifer R.} and Arteaga, {Carlos L.}",
year = "2019",
month = "2",
day = "15",
doi = "10.1158/0008-5472.CAN-18-4087",
language = "English (US)",
volume = "79",
journal = "Journal of Cancer Research",
issn = "0099-7013",
publisher = "American Association for Cancer Research Inc.",
number = "4",

}

TY - JOUR

T1 - Correction

T2 - Treatment of triple-negative breast cancer with TORC1/2 inhibitors sustains a drug-resistant and Notch-dependent cancer stem cell population (Cancer Research (2016) 76 (440–452) DOI: 10.1158/0008-5472.CAN-15-1640-T)

AU - Bhola, Neil E.

AU - Jansen, Valerie M.

AU - Koch, James P.

AU - Li, Hua

AU - Formisano, Luigi

AU - Williams, Janice A.

AU - Grandis, Jennifer R.

AU - Arteaga, Carlos L.

PY - 2019/2/15

Y1 - 2019/2/15

N2 - In the original version of this article (1), the stated disclosure of the author Carlos L. Arteaga is incorrect. The error has been corrected in the latest online HTML and PDF versions of the article. The authors regret this error.

AB - In the original version of this article (1), the stated disclosure of the author Carlos L. Arteaga is incorrect. The error has been corrected in the latest online HTML and PDF versions of the article. The authors regret this error.

UR - http://www.scopus.com/inward/record.url?scp=85061561767&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85061561767&partnerID=8YFLogxK

U2 - 10.1158/0008-5472.CAN-18-4087

DO - 10.1158/0008-5472.CAN-18-4087

M3 - Comment/debate

C2 - 30770370

AN - SCOPUS:85061561767

VL - 79

JO - Journal of Cancer Research

JF - Journal of Cancer Research

SN - 0099-7013

IS - 4

ER -